National Chapter Vision Webinar: Emerging Therapies and Research for Inherited Retinal Diseases

Saturday, November 12th, 2022, 12:00 pm–1:30 pm EDT

The 90-minute national webinar will feature guest presentations on emerging gene therapies from Opus, a potential anti-oxidative treatment from Nacuity, and a promising cell-based treatment from OkuloVision. The panel will answer questions from the audience on a wide range of research, clinical, and therapy development topics.
Get updates on Webinars


Virtual, MD


Sign up via Zoom

Register Today

Featured Speakers:

  • Jami R. Kern, MBA PhD, Nacuity Pharmaceuticals, SVP, Chief Clinical Officer
  • Marie Csete, MD, PhD, Chief Executive Officer, OkuloVision
  • Erin O'Neil, MD, VP of Clinical Development , Opus Genetics
  • Claire Gelfman, PhD, Chief Scientific Officer, Foundation Fighting Blindness
  • Ben Shaberman, VP, Science Communications, Foundation Fighting Blindness